Studied Doses for the CogniHoney Ingredients

Because an ingredient is a claim about quality and a dose is a claim about quantity, and a supplement can get the first right and the second wrong.

A trial that finds an effect at 300 mg of an extract says nothing about 30 mg, and a trial that finds harm at a large amount says nothing about a small one. Side effects tend to appear at high doses, when supplements replace prescribed medicines or when many are combined (NIH ODS, What You Need to Know). A dose is the other half of every study result.

In this product, the dose half is missing. The ingredient names are the sibling-pack list, and no milligram is printed. The honest position is that a studied dose is a yardstick, not a promise.

Because trials do not use plain powders.

The bacopa trials used three different extracts (Pase 2012, bacopa review), and the typical extract dose is 300 to 450 mg a day, often standardized to 24% to 55% bacosides (StatPearls, Bacopa monnieri). The list prints “(20%)” for bacopa, a figure below that range, with no stated meaning. We make no claim about what that means.

The same caution runs through the list. A plant powder is the ground leaf. An extract is that leaf concentrated, often many times over, so a milligram of extract carries far more of the active compounds than a milligram of powder. A label that mixes the terms can mislead without any false statement.

• Whether the capsules in your hand contain what the label says, since what is on the label may not be what is in the product (NCCIH, Using Dietary Supplements Wisely).
• Whether the same amount is safe with your medicines, your liver or your heart.
• Whether the trial population resembles you. GEM enrolled adults aged 75 or older.
• Whether combining eleven ingredients changes the picture. No trial tested the combination.

Studied amounts also come with outcomes that were small, such as faster reaction times, not a change you would notice in daily life. Read them as the edge of what is known, not a target.